The dexamethasone suppression test and combined dexamethasone (DEX)/CRH test are considered to measure glucocorticoid receptor-mediated negative feedback and often used as a surrogate marker in depression [178,179], which corresponds to the high clinical significance of the neuroendocrine hypothesis of depression. This evidence concerns the gene NR3C1 and depressive disorder.